B-cell lymphomas constitute a diverse group of malignancies originating from B lymphocytes, with dysregulation of transcriptional repressors such as BCL6 playing a pivotal role in disease pathogenesis ...
A rare mutation on the BCL6-corepressor gene correlated with worse overall survival in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). However, allogenic stem cell ...
NEW HAVEN, Conn., April 28, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, ...
Arvinas, Inc. announced that it will present new preclinical data on its investigational oral PROTAC BCL6 degrader, ARV-393, at the upcoming European Hematology Association (EHA) meeting in Milan from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback